Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Nakanishi, Yoshitsugu ^a,b   Ohara, Masanori ^a   Domen, Hiromitsu ^a,b   Shichinohe, Toshiaki ^b   Hirano, Satoshi ^b   Ishizaka, Masanori ^a  

^a Hakodate Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric carcinoma; Patterns of recurrence; Prognosis; Risk factor

Indexed keywords

GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; UFT;

ADULT; ADVANCED GASTRIC CARCINOMA; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREATICODUODENECTOMY; PERITONEUM METASTASIS; POSTOPERATIVE PERIOD; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; STOMACH CARCINOMA; TOTAL STOMACH RESECTION; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84877838065     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-98     Document Type: Article

References (21)

1. Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011, 14:113-123. Japanese Gastric Cancer Association.
2. Sobin LH, Gospodarowicz MK, Wittekind C. (Eds): TNM Classification of Malignant Tumours 2009, New York: Wiley-Blackwell, 7.
3. Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 2001, 84:1602-1609. 10.1054/bjoc.2001.1720, 2363675, 11401312.
4. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003, 90:1113-1119. 10.1002/bjs.4164, 12945079.
5. Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 2002, 9:394-400. 10.1007/BF02573875, 11986192.
6. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004, 240:808-816. 10.1097/01.sla.0000143245.28656.15, 1356486, 15492562.
7. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000, 87:236-242. 10.1046/j.1365-2168.2000.01360.x, 10671934.
8. Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A, Folli S, Cordiano C, Pinto E. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg 2002, 26:1160-1165. 10.1007/s00268-002-6344-2, 12209247.
9. Zheng HC, Zheng YS, Xia P, Xu XY, Xing YN, Takahashi H, Guan YF, Takano Y. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes. Histol Histopathol 2010, 25:445-452.
10. Aoyama T, Yoshikawa T, Hayashi T, Kuwabara H, Mikayama Y, Ogata T, Cho H, Tsuburaya A. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy. Ann Surg Oncol 2012, 19:1568-1574. 10.1245/s10434-011-2158-5, 22143578.
11. Otsuji E, Yamaguchi T, Sawai K, Sakakura C, Okamoto K, Takahashi T. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma. Am J Gastroenterol 1999, 94:434-437. 10.1111/j.1572-0241.1999.873_b.x, 10022642.
12. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H. Surgical outcome of serosa-negative advanced gastric carcinoma. Anticancer Res 2004, 24:3169-3175.
13. Lee HJ, Kim YH, Kim WH, Lee KU, Choe KJ, Kim JP, Yang HK. Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol 2003, 33:209-214. 10.1093/jjco/hyg042, 12865463.
14. Saka M, Katai H, Fukagawa T, Nijjar R, Sano T. Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer 2008, 11:214-218. 10.1007/s10120-008-0485-4, 19132483.
15. Ikeguchi M, Katano K, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between hematogenic metastasis of gastric cancer and the maximum extent of venous invasion by cancer cells in the gastric wall. Hepatogastroenterology 1995, 42:660-665.
16. Noguchi Y. Blood vessel invasion in gastric carcinoma. Surgery 1990, 107:140-148.
17. Kodera Y, Ito S, Mochizuki Y, Yamamura Y, Misawa K, Ohashi N, Nakayama G, Koike M, Fujiwara M, Nakao A. The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma. World J Surg 2008, 32:2015-2020. 10.1007/s00268-008-9672-z, 18563480.
18. Adachi Y, Kamakura T, Mori M, Baba H, Maehara Y, Sugimachi K. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994, 81:414-416. 10.1002/bjs.1800810331, 8173916.
19. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M, Kaibara N. Prediction of survival period for patients with postoperative recurrence after curative resection for advanced gastric carcinoma. Hepatogastroenterology 2001, 48:290-293.
20. Nozoe T, Iguchi T, Egashira A, Adachi E, Matsukuma A, Ezaki T. Pathological prognostic score as a simple criterion to predict outcome in gastric carcinoma. J Surg Oncol 2010, 102:73-76. 10.1002/jso.21586, 20578082.
21. Deng J, Liang H, Sun D, Pan Y. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res 2010, 161:47-53. 10.1016/j.jss.2008.12.019, 19783008.